Group Menu ->
Home
Search
Careers
Investors
News
Contact Us
×
No Results
Global
Australia
Austria
Azerbaijan
Brazil
Belgium
Canada
Chile
China
Costa Rica
Croatia
Czech Republic
Denmark
ESTONIA
Finland
France
Germany
Hong Kong
Hungary
India
Italy
Ireland
Japan
Korea
Latvia
Lithuania
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Philippines
Poland
Portugal
Romania
Singapore
Slovakia
Slovenia
Spain
Sweden
Switzerland
Taiwan
Turkey
United Kingdom
UNITED ARAB EMIRATES
United States
Vietnam
Menu
Home
Discovery
Services
in-vitro-pharmacology
selectivity-panels
gpcrs
binding
functional
allosteric
kinases
biochemical
ion-channels
binding
cardiacprofiler
functional
epigenetics
nuclear-receptors
transporters
drug
neurotransmitter
pdes
proteases
ubiquitin
e3-ligases
dubs
phosphatases
cytochrome-p450
cell-based-phenotypic
oncology
oncopanel-3d
large-molecule-biologics
epigenetic-therapeutics
drug-combinations
functional-toxicity
anti-infectives
immunology
cytokine-storm
adme-tox
bioavailability
solubility
absorption
drug-drug-interactions
cyp-induction
metabolism-stability
drug-transporters
metabolite-identification
in-vitro-toxicity
cardiotoxicity
cytotoxicity
genotoxicity
ames-test
in-vitro-micronucleus-assay
hepatotoxicity
nephrotoxicity
custom-services
protein-production
cell-line-development
assay-development
Products
Membrane Preps
GPCRs
Frozen Cells
GPCRs
Ion Channels
Enzymes
Ubiquitin
Phosphatases
Kinases
Epigenetics
Assay Kits
HTRF Lipid Kinase
Cell Lines
GPCRs
Ion Channels
View our Catalog
About Us
history
platforms
our-expertise
career-opportunities
events
News
Contact Us
New Eurofins Discovery Website
Resources
posters
webinars
Eurofins 3 June 2019 Press Release
Early Development
About Us
Our Services
ADME Analysis
Bioanalytics
Clinical Expertise
Immunoanalytics
Biomarker Analysis Services
Immunogenicity Testing Services
Pharmacokinetic Assay Services
Cellular Immunology Testing
PBMC Services
Flow Cytometry
Pharmacology
Dermal absorption studies
Preclinical
Bioassays
Toxicology Studies
Downloads
Pharma Services Newsletter
Locations
Bioanalysis
Immunogenicity Assays
Instrumentation
Immunogenicity Resources
PK and TK Services
Instrumentation
TK and PK Resources
Biomarker Testing Services
Biomarker Menu
Custom Assay Development
Flow Cytometry
Qualified Flow Cytometry Immunophenotyping Assays
Instrumentation
Biomarkers Resources
Biosimilar Testing
Trastuzumab Assays
Bevacizumab Assays
Cetuximab PK Assay
Adalimumab Assays
Instrumentation
Biosimilars Resources
Quality
Awards
Consulting
About Us
Latest News
Locations
Terms & Conditions
Pharma Newsletter
BioPharma Services Descriptions
BioPharma Newsletter
Resources
Webinars
Contact Us
Vaccine Development
Central Lab
Breaking News!
Testing
Support Services
Investigator Services
Global Coverage
Innovation
Quality
On-Demand Webinars
About Us
quality
accreditations-and-certifications
Contact
Product Testing
About Us
Laboratory of Choice
2023 CRO Leadership Award Winner
Service Models
Services
BioPharma Product Testing Services
Quality Control
Method Establishment
Raw Materials and Excipient Testing
Residual Solvents Testing
Trace Metals Testing
Water Determination by Karl Fischer
Microbial Limits Testing for Raw Materials
Raw Materials Testing for Biologics
USP <90> Compendial Quality & Function Testing of Fetal Bovine Serum
Product Stability Testing and Storage
Critical Reagents and Reference Standards
GMP Storage
Packaging Testing
Extractables and Leachables Testing
E&L Programs for Complex Dosage Forms and High-Risk Drug Products
Container Closure Integrity Testing
Containers Testing
Shipping Distribution Studies
Pharmaceutical Release Testing
Biopharmaceutical Release Testing
Pharmaceutical Gas Testing
Viral Safety Testing
Cell Line Characterization and Product Testing for CHO-Derived Biopharmaceutical Products
Unprocessed Bulk Testing
Raw Materials Testing for Biologics
Raw Materials Testing for Cell & Gene Therapy
USP <90> Compendial Quality & Function Testing of Fetal Bovine Serum
Particulate Matter Testing
EU Product Release
Cell Banking
Cell Line Characterization and Product Testing for CHO-Derived Biopharmaceutical Products
DNA Sizing and Barcoding
Cell Bank Preparation
HEK-293/T Cell Bank Testing
Genetic Stability
Process Validation
Residuals Testing for Bioprocess Validation
Viral Clearance
Facility Monitoring and Support
Cleaning Validation and Disinfectant Efficacy Studies
Method Development
Method Establishment
Comparator Products Testing
Extractables & Leachables
Water Determination by Karl Fischer
Method Transfer
Characterization
Characterization for Pharmaceutical Products
Solid State Characterization
Physico-Chemical Characterization of Biopharmaceutical Products
NMR Characterization and QC Testing
Impurities Testing
Extractables and Leachables
Residual Solvents
Trace Metals
Nitrosamine Impurities
Residuals Testing for Bioprocess Validation
Comparator Product Testing
Bioassay and cGMP Potency Testing
Bioassays for Gene Therapy Products
Biosimilar Potency Assays
Microbiology
Sterile and Non-Sterile Product Testing
Facility and Process Validation
Microorganism Identification and Typing
Mycoplasma Testing
Rapid Sterility Testing
Clinical Trial Support
Clinical Trial Materials Management
Clinical Trials Logistics
Raw Materials and Excipient Testing
Containers Testing
Comparator Product Testing
Pharmaceutical Release Testing
Shipping Distribution Studies
Toxicology
Genetic Toxicology
Alternative Toxicology
Biosafety Testing
Cell Bank Preparation
Lot Release Testing
Viral Clearance
Viral Safety Testing
Biologics Raw Materials Testing
Custom and cGMP Radiolabeling
Gene and Cell Therapy
Raw Materials Testing
Rapid Sterility Testing
Autologous Cell Therapy
Allogeneic Cell Therapy
Viral Vectors for Gene Therapy
Bioassays for Gene Therapy Products
Plasmid GMP Testing
Category 5, Highly Potent/Toxic Materials Testing
Regulatory and Quality Consulting Services
EU Product Release
Annex 1: The road to compliance
PSS Insourcing Solutions
Medical Device Testing
Sterile Fill/Finish Manufacturing
Human Factors Testing
Services by Modality
Antibody Drug Conjugates Testing Services
Oligonucleotides Testing Services
Oligonucleotide Analysis
GMP Testing for mRNA-Based Drugs
Cell Therapy Testing Services
Autologous Cell Therapy Services
Allogeneic Cell Therapy Services
Gene Therapy Testing Services
Testing of Viral Vector Gene Therapies
Plasmid GMP Testing
HEK-293/T Cell Bank Testing
Monoclonal Antibodies Testing Services
Peptides Testing Services
Therapeutic Proteins Testing Services
Oncolytic Virus Testing Services
Small Molecule Testing Services
Biotherapeutic Products/Microbiome
Ophthalmic Testing Services
Locations
Australia
Belgium
Canada
China
Czech Republic
Denmark
France
Germany
Hungary
India
Ireland
Italy
Japan
Netherlands
New Zealand
Slovakia
Spain
Sweden
Switzerland
UK
USA
Resources
Articles
Flyers
Technical Whitepapers
LabAccess.com
LabAccess - What's New
Features
FAQ
LabAccess Online Ordering
Glossary
News & Events
Press Releases
Conferences & Fairs
Webinars
Archived Webinars
Announcements
Newsletters
Spring 2022
Westward Ho!
Viral Safety doubles laboratory footprint
Sterility Testing Solutions for Every Project Need
Whitford & Smith advance to new leadership roles in Portage and Columbia
Major Stability expansion affords greater capacity and service opportunities
Human Factors MD acquisition
PSS Celebrates 20th Anniversary
Pamala Adams
Transition from R&D Cell Line Development to GMP Bank Manufacture
Fall 2022
Online Ordering to LAWS
Support next-generation biologics
EBPT San Diego offers cell based bioassays
Detection of mycobacterium species in qPCR
Eurofins BioPharma Product Testing ENCO expands US capabilities footprint
New Raw Materials Cell Based Services target cell viability and cell potency assays
Understanding the when, why, and how - Eurofins Human Factors MD
BioFire® assay
Micro’s new Bruker MALDI speeds organism identification
Scott Kingsley
Spring 2023
ENCO expands EBPT’s ophthalmic and medical device capabilities
The challenge to designing a Microbial Challenge Study
What to consider when planning a Viral Clearance Study
Regulatory Spotlight - Compendia Updates: USP <621> and USP <1220>
Sustainability - at the heart of what we do
Chris Walker
Fall 2023
The importance of a robust human factors engineering program
Eurofins BPT grows Cell & Gene Therapy US Footprint
Cell and Gene Therapies – When Speed Matters
TOX and CTM Manufacturing at Eurofins BPT
Honorable Mention in Sustainable Laboratory Awards
Helium Usage Management
Container Closure Integrity Testing needs
Business in Ethics Award
Eric Shaver
Contact Us
Clinical Diagnostics
Clinical Diagnostics Services
Reproductive Medicine
Women's Health
Oncology
Cardiology
Transplantation
Infectious Diseases
Neurology
Companion Diagnostics
Locations
Contact
CDMO
Services
Pre-Clinical - Safety & Efficacy Trials
Small Molecules - API Development & Manufacturing
API Development
API cGMP Manufacturing
API Commercialization Support
Fate & Purge services
Impurity Synthesis
Process Development
Fast Track Program
Small Molecules - Solid State Research and Development
Physicochemical Characterization
Polymorph Screening
Salt or Co-Crystal Screening
Solubility and Intrinsic Dissolution Screening
Chiral Resolution
Crystallization Process Development and Optimization
Small Molecules - DP Development & Manufacturing
Pre-Formulation / Formulation
Drug Product Development
Highly Potent / Cytotoxics
Micronization/Particle Size Reduction
Spray Drying
Biologics - DS/DP Development & Manufacturing
Cell Banking
Drug Substance
(Pre-)Formulation and Characterization for Biologics
Biologics Drug Product Development
Cell & Gene
Sterile Manufacturing / Fill & Finish
Lyophilization / Freeze drying cycle
Liquid and Powder
Non-Sterile Manufacturing
Liquids
Solids
Semi-solids
Clinical Trial Material, Packaging & Logistics
Primary Packaging
Secondary Packaging & Labeling
QP Services
GMP Storage & Distribution
Direct To Patient
Regulatory Services
IND / IMPD Services
NDA / CTD Services
Quality by Design
Cannabinoids - API/DP Development & Manufacturing
Pediatrics
Full clinical CRO and CDMO package
SynPure LPA - Linear PolyAcrylamide
Orphan Drugs
ADME, CDMO & OPTIMED
Locations
Belgium
France
India
USA and Canada
Resources
Articles
Brochures
Whitepapers
Scientific & Technical Posters
Presentations and Webinars
Videos
News & Events
Events
Press Releases
Contact Us
2023 Greetings | Eurofins CDMO
Media
Posters - Bioanalytical Services
Posters - Discovery Services
Posters - Global Central Laboratory
Flyers - Bioanalytical Services
Flyers - BioPharma Product Testing
Flyers - CDMO
Flyers - Early Development
Flyers - Genomic Services
Flyers - Global Central Laboratory
News & Announcements
Pharma Newsletters
Eurofins BioPharma Services Newsletter 37 - February 2024
Extractables LC/MS Search Engine offers a novel database for E&L identification
New FDA Guidance: Screening for Diethylene Glycol and Ethylene Glycol Contamination
Platform methods validated at Eurofins BPT: the future for ATMP analytics
Eurofins CDMO Alphora announces completion of a new pilot scale biologics development facility
Eurofins’ new Clinical Trial Supplies makes the complex simple
Eurofins Discovery accelerates Target Protein Degradation drug discovery
Eurofins BioPharma Services Newsletter 36 - October 2023
Oxidative stress in cell culture: getting the most from your growth factors
How effective is the cleaning process of my medical device?
A comprehensive testing solution for mycoplasma comparable validation
Eurofins Discovery presents obesityLITE Panel Fit-for-Purpose Solutions
Eurofins BPT Les Ulis at the forefront of inhalation products testing
Eurofins BioPharma Services expands its biological sample storage services with the Hamilton BiOS XL4, offering clients unparalleled safety and security
Eurofins BioPharma Services Newsletter 35 - June 2023
Genetic Abnormalities in Embryos
Integrity testing
Global Councils collaborate
Express Oxford Nanopore Sequencing service
High-throughput screening for discovery of novel solid forms
New site in China
Eurofins BioPharma Services Newsletter 34 - February 2023
TruGraf Liver
TEM
Healthcare Assurance
PFAs
35 YEARS OF EUROFINS
Sterile Drug Manufacturing
Eurofins BioPharma Services Newsletter 33 - October 2022
Detection of mycobacterium species in qPCR
Eurofins enhances vaccine development services
Simplifying the audit process for drug manufacturers
Eurofins BPT Italy expands efficacy testing capacity and capabilities against viruses
Testing for rouge metals
Ready for MDR
Eurofins BioPharma Services Newsletter 32 - June 2022
Eurofins Central Laboratory supports clinical trials in China’s regulatory landscape
Eurofins BPT Italy develops Container Closure Integrity Testing for Biologic Drugs with Pressure Decay technique
20 years of bringing managed laboratory services to client sites and exponential global growth
Eurofins BioPharma Product Testing Europe earns ISO 14001 certification
Eurofins BPT Kyoto offers foreign matter analysis services for CGT products
Eurofins Viracor expands
Eurofins BioPharma Services Newsletter 31 - February 2022
Eurofins BPT Toronto expands psychedelics testing and certification services to support mental health therapies
Eurofins CDMO helps solve the rising challenge of colon drug delivery for biologics
Organoids: the next step in precision oncology
The future of drug discovery
Eurofins BPT Italy expands biologics testing capacity with new fully operational BSL2 facility
Eurofins Central Laboratory solves PBMC processing challenges in global clinical trials
Eurofins BioPharma Services Newsletter 30 - October 2021
Eurofins Viracor targets precision oncology with the launch of PanCancerIQ
In Vitro potassium release assay for liposomal formulations of Amphotericin B – a requirement for Bio-IND applications
EU MDR requires onsite Person Responsible for Regulatory Compliance
Innovative particle size distribution and thermal analysis techniques are key to solving powder characterisation challenges
EBPT Ireland expands footprint into high-throughput glycoprofiling of biologics with 2-AB labelling, offering development, qualification and validation services
US Air Force awards $30 million contract to Eurofins Genomics to expand Oligonucleotide (DNA) capacity for diagnostic testing
Eurofins BioPharma Services Newsletter 29 - June 2021
Eurofins Viracor BioPharma partners with Moderna, performing essential clinical trial testing for COVID-19 Vaccine
Coumarin in cosmetics: Clarifying the safety controversy
Nanomilling for bioavailability enhancement: New capabilities at Eurofins CDMO in North America
Eurofins utilises ultrasensitive methods in the battle against neurodegeneration
Analytical Quality by Design: Eurofins BPT France delivers new level of expertise for methods development
Eurofins Biomnis is helping psychiatrists to optimise the choice of antidepressants in the treatment of depression
Eurofins BioPharma Services Newsletter 28 - February 2021
Eurofins Viracor BioPharma partners with Moderna, performing essential clinical trial testing for COVID-19 Vaccine
Eurofins holds a wealth of cGMP experience testing RNA based drugs
Eurofins Bioanalytical Services develops surrogate virus neutralising antibody detection assays against SARS-CoV-2
Targeting pro-inflammatory cytokines for COVID-19 therapy: Qualified cell-based assays for accelerated drug discovery
Eurofins launches new tests and massive capacity to detect and monitor new variants of SARS-CoV-2
Testing disinfectants for virucidal efficacy, a daily job at Eurofins!
Eurofins BioPharma Services Newsletter 27 - October 2020
New Category 5 suites deliver ADC free-drug testing & payload prep
N-Nitrosamine contamination of drug products
New WebLab System offers real-time formulation analysis services
Injectable products
Addition of Novocyte Quanteon™
Eurofins PSS
Eurofins BioPharma Services Newsletter 26 - July 2020
Complete solutions for transplant patients
CiPA initiative to form future industry regulatory guidelines
New B2B online shop for over 7,000 global Reference Standards
Eurofins BPT Bactup delivers expertise in crisis management and preventive consulting
Fast and effective PXRD technique for material characterisation
Eurofins BPT Ireland has expanded
Eurofins BioPharma Services Newsletter 25 - February 2020
Making liquid biopsy a reality for patients
Nitrosamine Impurities in pharmaceutical products - a “burning” topic for the industry
Quality by Design – A systemic approach to process development
Eliminating donor variability in ADCC Assays - implementation in QC Lot Release
Eurofins Viracor creates separate BioPharma Services Business
Considerations for selecting your partner for Biologics Characterisation
Eurofins BioPharma Services Newsletter 24 - October 2019
Development of cell and gene therapies
Early stage formulation strategy for a smooth drug product lifecycle
New state-of-the-art cryo storage
Validating drinking water disinfection
Accelerating biologics development programmes
PSS Insourcing Solutions
Eurofins BioPharma Services Newsletter 23 - June 2019
Phenotypic Drug Discovery
Improving cancer treatment with molecular diagnostics
Eurofins provides one-stop solution for biocidal products authorisation
CRISPR - the system that revolutionises gene editing
Self Emulsifying Drug Delivery Systems
Lancaster Labs building expansion
Eurofins BioPharma Services Newsletter 22 - February 2019
Integrated Drug Discovery
Medical Device Breathing Pathways
EU Medical Device regulation harmonisation
Engineering APIs to improve bioavailability
Administering drugs using food vehicles
Central Laboratory Shanghai
Eurofins BioPharma Services Newsletter 21 - October 2018
Compendial Testing
Eurofins CDMO
Protein formulation studies
Container closure integrity testing
Improving Patient Care
Eurofins BioPharma Services Newsletter 20 - June 2018
A smart approach to chemical characterisation
Eurofins provides custom synthesis and radiosynthesis capabilities
Bead-beating tissue homogenisation technology
Antibiotic assay validation
Alternative Skin Sensitisation Testing
Eurofins Scientific earns CRO Award
Eurofins BioPharma Services Newsletter 19 - February 2018
Charged Aerosol Detection
Package Testing Lab
Isotopic fingerprinting
Biological evaluation of medical devices
Bioanalytical and Molecular Cell Biology Testing
Eurofins BioPharma Services Newsletter 18 - November 2017
Next Generation Sequencing
Eurofins Scientific celebrates 30th Anniversary
Alternative methods for Medical Device Testing
Eurofins Pharma Bioanalytical Services launches new Consulting Business
Biopesticides
Contract Development & Manufacturing
Eurofins BioPharma Services Newsletter 17 - June 2017
Changes to EU Medical Device Legislation
Optimising Cytomegalovirus Outcomes
Golimumab
Insourcing Solutions
New solutions for Endocrine Disrupters
Eurofins BioPharma Services Newsletter 16 - March 2017
Cosmetic products: an overview of International Regulatory Systems
How similar is your biosimilar
GMP biosimilar bioassay needs
Eurofins Medical Device Testing
Extractable studies
Therapeutic products containing metal ions
Pharma Newsletter Archive
Contacts
Discovery
Services
Products
View our Catalog
About Us
Contact Us
New Eurofins Discovery Website
Resources
Eurofins 3 June 2019 Press Release
Early Development
About Us
Our Services
Downloads
Pharma Services Newsletter
Locations
Bioanalysis
Immunogenicity Assays
PK and TK Services
Biomarker Testing Services
Biosimilar Testing
Quality
Consulting
About Us
Resources
Contact Us
Vaccine Development
Central Lab
Breaking News!
Testing
Support Services
Investigator Services
Global Coverage
Innovation
Quality
On-Demand Webinars
About Us
Contact
Product Testing
About Us
Service Models
Services
Services by Modality
Locations
Resources
News & Events
Contact Us
Clinical Diagnostics
Clinical Diagnostics Services
Locations
Contact
CDMO
Services
Locations
Resources
News & Events
Contact Us
2023 Greetings | Eurofins CDMO
Media
Posters - Bioanalytical Services
Posters - Discovery Services
Posters - Global Central Laboratory
Flyers - Bioanalytical Services
Flyers - BioPharma Product Testing
Flyers - CDMO
Flyers - Early Development
Flyers - Genomic Services
Flyers - Global Central Laboratory
News & Announcements
Pharma Newsletters
Contacts
Eurofins
>>
BioPharma Services
>>
Media
>>
Pharma Newsletters
>> Pharma Newsletter Archive
Media
>>
Pharma Newsletters
>> Pharma Newsletter Archive
Search >>
Discovery
Services
in-vitro-pharmacology
selectivity-panels
gpcrs
binding
functional
allosteric
kinases
biochemical
ion-channels
binding
cardiacprofiler
functional
epigenetics
nuclear-receptors
transporters
drug
neurotransmitter
pdes
proteases
ubiquitin
e3-ligases
dubs
phosphatases
cytochrome-p450
cell-based-phenotypic
oncology
oncopanel-3d
large-molecule-biologics
epigenetic-therapeutics
drug-combinations
functional-toxicity
anti-infectives
immunology
cytokine-storm
adme-tox
bioavailability
solubility
absorption
drug-drug-interactions
cyp-induction
metabolism-stability
drug-transporters
metabolite-identification
in-vitro-toxicity
cardiotoxicity
cytotoxicity
genotoxicity
ames-test
in-vitro-micronucleus-assay
hepatotoxicity
nephrotoxicity
custom-services
protein-production
cell-line-development
assay-development
Products
Membrane Preps
GPCRs
Frozen Cells
GPCRs
Ion Channels
Enzymes
Ubiquitin
Phosphatases
Kinases
Epigenetics
Assay Kits
HTRF Lipid Kinase
Cell Lines
GPCRs
Ion Channels
View our Catalog
About Us
history
platforms
our-expertise
career-opportunities
events
News
Contact Us
New Eurofins Discovery Website
Resources
posters
webinars
Eurofins 3 June 2019 Press Release
Early Development
About Us
Our Services
ADME Analysis
Bioanalytics
Clinical Expertise
Immunoanalytics
Biomarker Analysis Services
Immunogenicity Testing Services
Pharmacokinetic Assay Services
Cellular Immunology Testing
PBMC Services
Flow Cytometry
Pharmacology
Dermal absorption studies
Preclinical
Bioassays
Toxicology Studies
Downloads
Pharma Services Newsletter
Locations
Bioanalysis
Immunogenicity Assays
Instrumentation
Immunogenicity Resources
PK and TK Services
Instrumentation
TK and PK Resources
Biomarker Testing Services
Biomarker Menu
Custom Assay Development
Flow Cytometry
Qualified Flow Cytometry Immunophenotyping Assays
Instrumentation
Biomarkers Resources
Biosimilar Testing
Trastuzumab Assays
Bevacizumab Assays
Cetuximab PK Assay
Adalimumab Assays
Instrumentation
Biosimilars Resources
Quality
Awards
Consulting
About Us
Latest News
Locations
Terms & Conditions
Pharma Newsletter
BioPharma Services Descriptions
BioPharma Newsletter
Resources
Webinars
Contact Us
Vaccine Development
Central Lab
Breaking News!
Testing
Support Services
Investigator Services
Global Coverage
Innovation
Quality
On-Demand Webinars
About Us
quality
accreditations-and-certifications
Contact
Product Testing
About Us
Laboratory of Choice
2023 CRO Leadership Award Winner
Service Models
Services
BioPharma Product Testing Services
Quality Control
Method Establishment
Raw Materials and Excipient Testing
Residual Solvents Testing
Trace Metals Testing
Water Determination by Karl Fischer
Microbial Limits Testing for Raw Materials
Raw Materials Testing for Biologics
USP <90> Compendial Quality & Function Testing of Fetal Bovine Serum
Product Stability Testing and Storage
Critical Reagents and Reference Standards
GMP Storage
Packaging Testing
Extractables and Leachables Testing
E&L Programs for Complex Dosage Forms and High-Risk Drug Products
Container Closure Integrity Testing
Containers Testing
Shipping Distribution Studies
Pharmaceutical Release Testing
Biopharmaceutical Release Testing
Pharmaceutical Gas Testing
Viral Safety Testing
Cell Line Characterization and Product Testing for CHO-Derived Biopharmaceutical Products
Unprocessed Bulk Testing
Raw Materials Testing for Biologics
Raw Materials Testing for Cell & Gene Therapy
USP <90> Compendial Quality & Function Testing of Fetal Bovine Serum
Particulate Matter Testing
EU Product Release
Cell Banking
Cell Line Characterization and Product Testing for CHO-Derived Biopharmaceutical Products
DNA Sizing and Barcoding
Cell Bank Preparation
HEK-293/T Cell Bank Testing
Genetic Stability
Process Validation
Residuals Testing for Bioprocess Validation
Viral Clearance
Facility Monitoring and Support
Cleaning Validation and Disinfectant Efficacy Studies
Method Development
Method Establishment
Comparator Products Testing
Extractables & Leachables
Water Determination by Karl Fischer
Method Transfer
Characterization
Characterization for Pharmaceutical Products
Solid State Characterization
Physico-Chemical Characterization of Biopharmaceutical Products
NMR Characterization and QC Testing
Impurities Testing
Extractables and Leachables
Residual Solvents
Trace Metals
Nitrosamine Impurities
Residuals Testing for Bioprocess Validation
Comparator Product Testing
Bioassay and cGMP Potency Testing
Bioassays for Gene Therapy Products
Biosimilar Potency Assays
Microbiology
Sterile and Non-Sterile Product Testing
Facility and Process Validation
Microorganism Identification and Typing
Mycoplasma Testing
Rapid Sterility Testing
Clinical Trial Support
Clinical Trial Materials Management
Clinical Trials Logistics
Raw Materials and Excipient Testing
Containers Testing
Comparator Product Testing
Pharmaceutical Release Testing
Shipping Distribution Studies
Toxicology
Genetic Toxicology
Alternative Toxicology
Biosafety Testing
Cell Bank Preparation
Lot Release Testing
Viral Clearance
Viral Safety Testing
Biologics Raw Materials Testing
Custom and cGMP Radiolabeling
Gene and Cell Therapy
Raw Materials Testing
Rapid Sterility Testing
Autologous Cell Therapy
Allogeneic Cell Therapy
Viral Vectors for Gene Therapy
Bioassays for Gene Therapy Products
Plasmid GMP Testing
Category 5, Highly Potent/Toxic Materials Testing
Regulatory and Quality Consulting Services
EU Product Release
Annex 1: The road to compliance
PSS Insourcing Solutions
Medical Device Testing
Sterile Fill/Finish Manufacturing
Human Factors Testing
Services by Modality
Antibody Drug Conjugates Testing Services
Oligonucleotides Testing Services
Oligonucleotide Analysis
GMP Testing for mRNA-Based Drugs
Cell Therapy Testing Services
Autologous Cell Therapy Services
Allogeneic Cell Therapy Services
Gene Therapy Testing Services
Testing of Viral Vector Gene Therapies
Plasmid GMP Testing
HEK-293/T Cell Bank Testing
Monoclonal Antibodies Testing Services
Peptides Testing Services
Therapeutic Proteins Testing Services
Oncolytic Virus Testing Services
Small Molecule Testing Services
Biotherapeutic Products/Microbiome
Ophthalmic Testing Services
Locations
Australia
Belgium
Canada
China
Czech Republic
Denmark
France
Germany
Hungary
India
Ireland
Italy
Japan
Netherlands
New Zealand
Slovakia
Spain
Sweden
Switzerland
UK
USA
Resources
Articles
Flyers
Technical Whitepapers
LabAccess.com
LabAccess - What's New
Features
FAQ
LabAccess Online Ordering
Glossary
News & Events
Press Releases
Conferences & Fairs
Webinars
Archived Webinars
Announcements
Newsletters
Spring 2022
Westward Ho!
Viral Safety doubles laboratory footprint
Sterility Testing Solutions for Every Project Need
Whitford & Smith advance to new leadership roles in Portage and Columbia
Major Stability expansion affords greater capacity and service opportunities
Human Factors MD acquisition
PSS Celebrates 20th Anniversary
Pamala Adams
Transition from R&D Cell Line Development to GMP Bank Manufacture
Fall 2022
Online Ordering to LAWS
Support next-generation biologics
EBPT San Diego offers cell based bioassays
Detection of mycobacterium species in qPCR
Eurofins BioPharma Product Testing ENCO expands US capabilities footprint
New Raw Materials Cell Based Services target cell viability and cell potency assays
Understanding the when, why, and how - Eurofins Human Factors MD
BioFire® assay
Micro’s new Bruker MALDI speeds organism identification
Scott Kingsley
Spring 2023
ENCO expands EBPT’s ophthalmic and medical device capabilities
The challenge to designing a Microbial Challenge Study
What to consider when planning a Viral Clearance Study
Regulatory Spotlight - Compendia Updates: USP <621> and USP <1220>
Sustainability - at the heart of what we do
Chris Walker
Fall 2023
The importance of a robust human factors engineering program
Eurofins BPT grows Cell & Gene Therapy US Footprint
Cell and Gene Therapies – When Speed Matters
TOX and CTM Manufacturing at Eurofins BPT
Honorable Mention in Sustainable Laboratory Awards
Helium Usage Management
Container Closure Integrity Testing needs
Business in Ethics Award
Eric Shaver
Contact Us
Clinical Diagnostics
Clinical Diagnostics Services
Reproductive Medicine
Women's Health
Oncology
Cardiology
Transplantation
Infectious Diseases
Neurology
Companion Diagnostics
Locations
Contact
CDMO
Services
Pre-Clinical - Safety & Efficacy Trials
Small Molecules - API Development & Manufacturing
API Development
API cGMP Manufacturing
API Commercialization Support
Fate & Purge services
Impurity Synthesis
Process Development
Fast Track Program
Small Molecules - Solid State Research and Development
Physicochemical Characterization
Polymorph Screening
Salt or Co-Crystal Screening
Solubility and Intrinsic Dissolution Screening
Chiral Resolution
Crystallization Process Development and Optimization
Small Molecules - DP Development & Manufacturing
Pre-Formulation / Formulation
Drug Product Development
Highly Potent / Cytotoxics
Micronization/Particle Size Reduction
Spray Drying
Biologics - DS/DP Development & Manufacturing
Cell Banking
Drug Substance
(Pre-)Formulation and Characterization for Biologics
Biologics Drug Product Development
Cell & Gene
Sterile Manufacturing / Fill & Finish
Lyophilization / Freeze drying cycle
Liquid and Powder
Non-Sterile Manufacturing
Liquids
Solids
Semi-solids
Clinical Trial Material, Packaging & Logistics
Primary Packaging
Secondary Packaging & Labeling
QP Services
GMP Storage & Distribution
Direct To Patient
Regulatory Services
IND / IMPD Services
NDA / CTD Services
Quality by Design
Cannabinoids - API/DP Development & Manufacturing
Pediatrics
Full clinical CRO and CDMO package
SynPure LPA - Linear PolyAcrylamide
Orphan Drugs
ADME, CDMO & OPTIMED
Locations
Belgium
France
India
USA and Canada
Resources
Articles
Brochures
Whitepapers
Scientific & Technical Posters
Presentations and Webinars
Videos
News & Events
Events
Press Releases
Contact Us
2023 Greetings | Eurofins CDMO
Media
Posters - Bioanalytical Services
Posters - Discovery Services
Posters - Global Central Laboratory
Flyers - Bioanalytical Services
Flyers - BioPharma Product Testing
Flyers - CDMO
Flyers - Early Development
Flyers - Genomic Services
Flyers - Global Central Laboratory
News & Announcements
Pharma Newsletters
Eurofins BioPharma Services Newsletter 37 - February 2024
Extractables LC/MS Search Engine offers a novel database for E&L identification
New FDA Guidance: Screening for Diethylene Glycol and Ethylene Glycol Contamination
Platform methods validated at Eurofins BPT: the future for ATMP analytics
Eurofins CDMO Alphora announces completion of a new pilot scale biologics development facility
Eurofins’ new Clinical Trial Supplies makes the complex simple
Eurofins Discovery accelerates Target Protein Degradation drug discovery
Eurofins BioPharma Services Newsletter 36 - October 2023
Oxidative stress in cell culture: getting the most from your growth factors
How effective is the cleaning process of my medical device?
A comprehensive testing solution for mycoplasma comparable validation
Eurofins Discovery presents obesityLITE Panel Fit-for-Purpose Solutions
Eurofins BPT Les Ulis at the forefront of inhalation products testing
Eurofins BioPharma Services expands its biological sample storage services with the Hamilton BiOS XL4, offering clients unparalleled safety and security
Eurofins BioPharma Services Newsletter 35 - June 2023
Genetic Abnormalities in Embryos
Integrity testing
Global Councils collaborate
Express Oxford Nanopore Sequencing service
High-throughput screening for discovery of novel solid forms
New site in China
Eurofins BioPharma Services Newsletter 34 - February 2023
TruGraf Liver
TEM
Healthcare Assurance
PFAs
35 YEARS OF EUROFINS
Sterile Drug Manufacturing
Eurofins BioPharma Services Newsletter 33 - October 2022
Detection of mycobacterium species in qPCR
Eurofins enhances vaccine development services
Simplifying the audit process for drug manufacturers
Eurofins BPT Italy expands efficacy testing capacity and capabilities against viruses
Testing for rouge metals
Ready for MDR
Eurofins BioPharma Services Newsletter 32 - June 2022
Eurofins Central Laboratory supports clinical trials in China’s regulatory landscape
Eurofins BPT Italy develops Container Closure Integrity Testing for Biologic Drugs with Pressure Decay technique
20 years of bringing managed laboratory services to client sites and exponential global growth
Eurofins BioPharma Product Testing Europe earns ISO 14001 certification
Eurofins BPT Kyoto offers foreign matter analysis services for CGT products
Eurofins Viracor expands
Eurofins BioPharma Services Newsletter 31 - February 2022
Eurofins BPT Toronto expands psychedelics testing and certification services to support mental health therapies
Eurofins CDMO helps solve the rising challenge of colon drug delivery for biologics
Organoids: the next step in precision oncology
The future of drug discovery
Eurofins BPT Italy expands biologics testing capacity with new fully operational BSL2 facility
Eurofins Central Laboratory solves PBMC processing challenges in global clinical trials
Eurofins BioPharma Services Newsletter 30 - October 2021
Eurofins Viracor targets precision oncology with the launch of PanCancerIQ
In Vitro potassium release assay for liposomal formulations of Amphotericin B – a requirement for Bio-IND applications
EU MDR requires onsite Person Responsible for Regulatory Compliance
Innovative particle size distribution and thermal analysis techniques are key to solving powder characterisation challenges
EBPT Ireland expands footprint into high-throughput glycoprofiling of biologics with 2-AB labelling, offering development, qualification and validation services
US Air Force awards $30 million contract to Eurofins Genomics to expand Oligonucleotide (DNA) capacity for diagnostic testing
Eurofins BioPharma Services Newsletter 29 - June 2021
Eurofins Viracor BioPharma partners with Moderna, performing essential clinical trial testing for COVID-19 Vaccine
Coumarin in cosmetics: Clarifying the safety controversy
Nanomilling for bioavailability enhancement: New capabilities at Eurofins CDMO in North America
Eurofins utilises ultrasensitive methods in the battle against neurodegeneration
Analytical Quality by Design: Eurofins BPT France delivers new level of expertise for methods development
Eurofins Biomnis is helping psychiatrists to optimise the choice of antidepressants in the treatment of depression
Eurofins BioPharma Services Newsletter 28 - February 2021
Eurofins Viracor BioPharma partners with Moderna, performing essential clinical trial testing for COVID-19 Vaccine
Eurofins holds a wealth of cGMP experience testing RNA based drugs
Eurofins Bioanalytical Services develops surrogate virus neutralising antibody detection assays against SARS-CoV-2
Targeting pro-inflammatory cytokines for COVID-19 therapy: Qualified cell-based assays for accelerated drug discovery
Eurofins launches new tests and massive capacity to detect and monitor new variants of SARS-CoV-2
Testing disinfectants for virucidal efficacy, a daily job at Eurofins!
Eurofins BioPharma Services Newsletter 27 - October 2020
New Category 5 suites deliver ADC free-drug testing & payload prep
N-Nitrosamine contamination of drug products
New WebLab System offers real-time formulation analysis services
Injectable products
Addition of Novocyte Quanteon™
Eurofins PSS
Eurofins BioPharma Services Newsletter 26 - July 2020
Complete solutions for transplant patients
CiPA initiative to form future industry regulatory guidelines
New B2B online shop for over 7,000 global Reference Standards
Eurofins BPT Bactup delivers expertise in crisis management and preventive consulting
Fast and effective PXRD technique for material characterisation
Eurofins BPT Ireland has expanded
Eurofins BioPharma Services Newsletter 25 - February 2020
Making liquid biopsy a reality for patients
Nitrosamine Impurities in pharmaceutical products - a “burning” topic for the industry
Quality by Design – A systemic approach to process development
Eliminating donor variability in ADCC Assays - implementation in QC Lot Release
Eurofins Viracor creates separate BioPharma Services Business
Considerations for selecting your partner for Biologics Characterisation
Eurofins BioPharma Services Newsletter 24 - October 2019
Development of cell and gene therapies
Early stage formulation strategy for a smooth drug product lifecycle
New state-of-the-art cryo storage
Validating drinking water disinfection
Accelerating biologics development programmes
PSS Insourcing Solutions
Eurofins BioPharma Services Newsletter 23 - June 2019
Phenotypic Drug Discovery
Improving cancer treatment with molecular diagnostics
Eurofins provides one-stop solution for biocidal products authorisation
CRISPR - the system that revolutionises gene editing
Self Emulsifying Drug Delivery Systems
Lancaster Labs building expansion
Eurofins BioPharma Services Newsletter 22 - February 2019
Integrated Drug Discovery
Medical Device Breathing Pathways
EU Medical Device regulation harmonisation
Engineering APIs to improve bioavailability
Administering drugs using food vehicles
Central Laboratory Shanghai
Eurofins BioPharma Services Newsletter 21 - October 2018
Compendial Testing
Eurofins CDMO
Protein formulation studies
Container closure integrity testing
Improving Patient Care
Eurofins BioPharma Services Newsletter 20 - June 2018
A smart approach to chemical characterisation
Eurofins provides custom synthesis and radiosynthesis capabilities
Bead-beating tissue homogenisation technology
Antibiotic assay validation
Alternative Skin Sensitisation Testing
Eurofins Scientific earns CRO Award
Eurofins BioPharma Services Newsletter 19 - February 2018
Charged Aerosol Detection
Package Testing Lab
Isotopic fingerprinting
Biological evaluation of medical devices
Bioanalytical and Molecular Cell Biology Testing
Eurofins BioPharma Services Newsletter 18 - November 2017
Next Generation Sequencing
Eurofins Scientific celebrates 30th Anniversary
Alternative methods for Medical Device Testing
Eurofins Pharma Bioanalytical Services launches new Consulting Business
Biopesticides
Contract Development & Manufacturing
Eurofins BioPharma Services Newsletter 17 - June 2017
Changes to EU Medical Device Legislation
Optimising Cytomegalovirus Outcomes
Golimumab
Insourcing Solutions
New solutions for Endocrine Disrupters
Eurofins BioPharma Services Newsletter 16 - March 2017
Cosmetic products: an overview of International Regulatory Systems
How similar is your biosimilar
GMP biosimilar bioassay needs
Eurofins Medical Device Testing
Extractable studies
Therapeutic products containing metal ions
Pharma Newsletter Archive
Contacts
<< Return to BioPharma Services
Eurofins Pharma Newsletter Archive
Eurofins BioPharma Services Newsletter 19 - February 2018
Eurofins BioPharma Services Newsletter 18 - November 2017
Eurofins BioPharma Services Newsletter 17 - June 2017
Eurofins BioPharma Services Newsletter 16 - March 2017
Eurofins BioPharma Services Newsletter 15 - October 2016
Eurofins Pharma Services Newsletter 14 - June 2016
Eurofins Pharma Services Newsletter 13 - March 2016
Eurofins Pharma Services Newsletter 12 - October 2015
Eurofins Pharma Services Newsletter 11 - June 2015
Eurofins Pharma Services Newsletter 10 - February 2015
Eurofins Pharma Services Newsletter 09 - October 2014
Eurofins Pharma Services Newsletter 08 - June 2014
Pharma services newsletter 07 - February 2014
Pharma services newsletter 06 - November 2013
Pharma services newsletter 05 - June 2013
Pharma services newsletter 04 - February 2013
Pharma services newsletter 03 - October 2012
Pharma services newsletter 02 - June 2012
Pharma services newsletter 01 - February 2012
Country
Worldwide
Argentina
Australia
Austria
Bahrain
Bangladesh
Belgium
Brazil
Bulgaria
Cambodia
Canada
Chile
China
Colombia
Costa Rica
Croatia
Czech Republic
Denmark
Estonia
Finland
France
French Guiana
Germany
Greece
Hong Kong (China)
Hungary
India
Indonesia
Ireland
Israel
Italy
Japan
Korea
Lithuania
Luxembourg
Malaysia
Martinique
Mauritius
Morocco
Myanmar
The Netherlands
New Zealand
Norway
Pakistan
Philippines
Poland
Portugal
Romania
Saudi Arabia
Singapore
Slovakia
Slovenia
South Africa
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Thailand
Tunisia
Turkey
United Arab Emirates
United Kingdom
USA
Vietnam
Country
Worldwide
Argentina
Australia
Austria
Bahrain
Bangladesh
Belgium
Brazil
Bulgaria
Cambodia
Canada
Chile
China
Colombia
Costa Rica
Croatia
Czech Republic
Denmark
Estonia
Finland
France
French Guiana
Germany
Greece
Hong Kong (China)
Hungary
India
Indonesia
Ireland
Israel
Italy
Japan
Korea
Lithuania
Luxembourg
Malaysia
Martinique
Mauritius
Morocco
Myanmar
The Netherlands
New Zealand
Norway
Pakistan
Philippines
Poland
Portugal
Romania
Saudi Arabia
Singapore
Slovakia
Slovenia
South Africa
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Thailand
Tunisia
Turkey
United Arab Emirates
United Kingdom
USA
Vietnam
Contact Us
